-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Agilon Health, Lowers Price Target to $1

Benzinga·11/05/2025 15:08:27
Listen to the news
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $1.5 to $1.